IFPMA and members took part in the seventh Scientific Conference on Medical Product Regulation in Africa (SCoMRA), which took from 11 – 13 November 2025 in Mombasa, Kenya. The conference is a platform that brings stakeholders together to discuss advances in regulatory science, reflect on progress on strengthening and harmonization of regulatory systems, define priorities, and set the agenda going forward using an evidence-based approach.

IFPMA and member experts have been involved in several sessions at SCoMRA, leveraging industry expertise on the following topics:

• From AMRH to AMA – Anchoring Africa’s regulatory future – Sarah Adam
• Countering substandard and falsified medicinal products – data systems, technology and collaborative approaches – Saba Berhane
• Insights from the continental pilot on the listing of human medicinal products – Christine Ledimo
• Regulatory reliance – a strategic pathway for Africa – John Mwangi
• Harnessing innovation & AI across the regulatory & manufacturing ecosystem – Amira Younes
• Retrospective assessment EAC MRH – A company case study, John Mwangi
• Clinical trials & global lessons in regulatory preparedness – Angelika Joos
• Building resilient regulatory systems for quality medicines in Africa – Zainab Aziz

As a strategic partner, IFPMA worked closely with AUDA-NEPAD in co-hosting the Industry Engagement Day, which included perspectives on:

• Industry reflections of AMA continental listing pilot – Nevena Miletic and Christine Ledimo
• Future directions: discussion on sample management/ in country testing, templates and lifecycle management – Zainab Aziz
• Industry perspective on fee for service model – Angelika Joos
• Next Phase: transition to AMA – Bunmi Femi-Oyekan

See the full programme here.